In the present study, we demonstrated that high CCL5 expression was significantly correlated with high Gleason grade, poor prognosis, metastasis as well as increased PCSCs activity in prostate cancer patients by conducting clinical investigations and bioinformatic analysis. Here, CCL5 is linked to prostate cancer.